NRC Health’s $20.34 close reflects a 9.3% YTD gain, driven by robust earnings and a record backlog in Q2 2026.
NRC Health (NASDAQ:NRC) closed at $20.34 on August 7, 2026, marking a 9.3% year-to-date increase and a $449.9 million market capitalization. The company’s shares surged 35.95% over the past 52 weeks, despite a one-month dip of 6.02%.
Long Cast Advisers reported NRC Health’s strong Q2 2026 performance, citing a 20% earnings improvement and a cumulative 343% return since 2015. The firm’s strategy focuses on small and micro-cap investments, outperforming the iShares SmallCap EAFE ETF but trailing the Russell 2000.
The firm emphasized patience in volatile markets, avoiding margin risks while maintaining a concentrated portfolio. NRC Health’s analytics business continues to drive growth in the healthcare sector.